and political organizations; 4) establishment of a national guideline bureau; 5) guideline adoption; 6) multidimensional dissemination; 7) structured implementation on regional level; 8) controlled evaluation study. RESULTS: A national guideline bureau was established by the German Medical Association in 2002. In 2003 the Association of the Scientific Medical Societies (n ϭ 153) and Association of Statutory Health Insurance Physicians (n ϭ 120,500) joined the program and consented on a guideline methodology. By now guidelines for asthma, COPD, CHD, diabetes, CHF, depression, and low back pain were developed and disseminated. Consumer involvement in development and implementation of DM CPGs started in 2005. First-generation DM CPGs are in the process (diabetes, CHD) or already finished updating (asthma). DISCUSSION (CONCLUSION): A countrywide disease management guideline program was established within 4 years. Until 2011, 12 DM CPGs will be finalized and implementation into quality management systems and regional care settings will be established. TARGET AUDIENCE(S): 1. Clinical researcher 2. Guideline developer 3. Guideline implementer 4. Developer of guideline-based products 5. Quality improvement manager/facilitator 6. Health care policy analyst/policymaker 7. Health insurance payers and purchasers 8. Allied health professionals 9. Consumers' and patients' representatives S34-Development of revised recommendations for HIV counseling, testing, and linkage in nonhealth-care settings

independence." Only 16/33 (48.5%) CPG vs. 23/24 (96%) CS were published in journals. DISCUSSION (CONCLUSION): The quality of published guidelines in RA is variable, with few guidelines rating as high quality. CS were rated as lower than CPG. Less than half of CPG are published in journals, suggesting that broader search strategies for identifying CPG are warranted. TARGET AUDIENCE(S): 1. Clinical researcher 2. Evidence synthesizer, developer of systematic reviews or meta-analyses 3. Guideline developer 4. Guideline implementer 5. Developer of guideline-based products 6. Quality improvement manager/facilitator 7. Health care policy analyst/policy-maker 8. Medical providers and executives 9. Consumers and patients representatives P25-Simultaneous development of national sets of guidelines and quality indicators in the Czech Republic Milos Suchy, MD (Presenter)

Medical providers and executives 8. Allied health professionals 9. Consumers' and patients' representatives S32-Comparison of the quality and amount of guidelines identified by conventional database searches vs. extended systematic search methods Daniel Anzola, MD (Presenter)